These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 463736)
1. Kelsey's Commandos: FDA investigates the investigators. Small WE Am Pharm; 1979 Jun; 19(6):30-3. PubMed ID: 463736 [No Abstract] [Full Text] [Related]
3. Scientific misconduct in investigational drug trials. Shapiro MF; Charrow RP N Engl J Med; 1985 Mar; 312(11):731-6. PubMed ID: 3974649 [No Abstract] [Full Text] [Related]
4. Financial disclosure by clinical investigators--FDA. Final rule; action on petition for reconsideration. Fed Regist; 1998 Dec; 63(251):72171-81. PubMed ID: 10344800 [TBL] [Abstract][Full Text] [Related]
5. Desperation drugs. Frustrated AIDs patients are spurring the FDA to relax the rules of the game. Begley S; Hager M; Wilson L Newsweek; 1989 Aug; 114(6):48-9, 51. PubMed ID: 10293942 [No Abstract] [Full Text] [Related]
6. An interview with FDA Commissioner Frank Young. Interview by Carmella Bocchino. Young FE Nurs Econ; 1989; 7(5):242-8. PubMed ID: 2812067 [TBL] [Abstract][Full Text] [Related]
7. The process of drug decision making: perspectives of an FDA Commissioner. Hayes AH Hosp Formul; 1985 Aug; 20(8):896-900. PubMed ID: 10272396 [TBL] [Abstract][Full Text] [Related]
8. FDA paves the way for drug law reform. Eichelberger BM Am J Hosp Pharm; 1978 Jul; 35(7):878, 882. PubMed ID: 665706 [No Abstract] [Full Text] [Related]
9. Critics fear the FDA is going too far in cutting industry's regulatory load. Demkovich LE Natl J (Wash); 1982 Jul; 14(29):1249-52. PubMed ID: 10255878 [No Abstract] [Full Text] [Related]
10. Research provides golden opportunity for physicians. An overview of clinical trials and how to conduct them. Nylen RA Physician Exec; 2002; 28(1):32-7. PubMed ID: 11806227 [TBL] [Abstract][Full Text] [Related]
11. Radiopharmaceuticals and FDA: a clinician's perspective. Siegel BA Med Instrum; 1981; 15(6):355-60. PubMed ID: 7040923 [No Abstract] [Full Text] [Related]
12. FDA guidelines forthe clinical evaluation of psychotropic drugs--antidepressant and antianxiety drugs. Psychopharmacol Bull; 1978 Apr; 14(2):45-63. PubMed ID: 26103 [No Abstract] [Full Text] [Related]
13. A study of warning letters issued to clinical investigators by the United States Food and Drug Administration. Bramstedt KA Clin Invest Med; 2004 Jun; 27(3):129-34. PubMed ID: 15305804 [TBL] [Abstract][Full Text] [Related]
14. [Clinical drug testing in the United States]. Engelbart S Fortschr Med; 1983 Jun; 101(22):1021-2, 1049. PubMed ID: 6347848 [No Abstract] [Full Text] [Related]
15. Impact of FDA's new drug rule? Not much. Holthaus D Hospitals; 1987 Aug; 61(15):106. PubMed ID: 3596532 [No Abstract] [Full Text] [Related]
16. The Food and Drug Administration's requirements for approval of new dental drugs. Gilkes CC Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180 [No Abstract] [Full Text] [Related]
17. AIDS and the politics of drug lag. Vogel D Public Interest; 1989; (96):73-85. PubMed ID: 10294053 [No Abstract] [Full Text] [Related]
18. How bad the drug lag? Clark M; Hager M; Gosnell M Newsweek; 1978 Oct; 92(15):119, 121. PubMed ID: 10297213 [No Abstract] [Full Text] [Related]
19. Antiarrhythmic drug approval--an industry perspective. Jacobs S Can J Cardiol; 1991; 7(1):45-6; discussion 49-50. PubMed ID: 2025792 [No Abstract] [Full Text] [Related]
20. Obligations of clinical investigators of regulated articles--proposed establishment of regulations. Fed Regist; 1978 Aug; 43(153):35209-36. PubMed ID: 10237258 [No Abstract] [Full Text] [Related] [Next] [New Search]